Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation

Journal of Applied Physiology

Volumn 107, Issue 1, 2009, Pages 144-154

  Goodman, Craig A ^a,d   Horvath, Deanna ^a   Stathis, Christos ^a   Mori, Trevor ^b   Croft, Kevin ^b   Murphy, Robyn M ^c   Hayes, Alan ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Calpains; Lipid peroxidation; Low frequency fatigue; Muscle damage; Reactive oxygen species

Indexed keywords

CALPAIN; CALSEQUESTRIN; ISOPROSTANE; REACTIVE OXYGEN METABOLITE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 1; TAURINE; TAURINE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ELECTROSTIMULATION; EXTENSOR DIGITORUM LONGUS MUSCLE; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MUSCLE CONTRACTILITY; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MASS; MUSCLE TWITCH; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE;

ANIMALS; CARRIER PROTEINS; ELECTRIC STIMULATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; TAURINE; WATER SUPPLY;

EID: 67650079051     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00040.2009     Document Type: Article

References (75)

1. Allen DG, Whitehead NP, Yeung EW. Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes. J Physiol 567: 723-735, 2005.
2. Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev 88: 287-332, 2008.
3. Anderson LV, Davison K, Moss JA, Richard I, Fardeau M, Tomé FM, Hübner C, Lasa A, Colomer J, Beckmann JS. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol 153:1169-1179, 1998.
4. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256: 251-255, 1988.
5. Baki A, Tompa P, Alexa A, Molnar O, Friedrich P. Autolysis parallels activation of mu-calpain. Biochem J 318: 897-901, 1996.
6. Bakker AJ, Berg HM. Effect of taurine on sarcoplasmic reticulum function and force in skinned fast-twitch skeletal muscle fibres of the rat. J Physiol 538: 185-194, 2002.
7. 2 supply to isolated preparations of mammalian skeletal and cardiac muscle. J Muscle Res Cell Motil 26: 225-235, 2005.
8. Beard NA, Laver DR, Dulhunty AF. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 85: 33-69, 2004.
9. Brooks SV, Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404: 71-82, 1988.
10. Bruton JD, Lannergren J, Westerblad H. Mechanisms underlying the slow recovery of force after fatigue: importance of intracellular calcium. Acta Physiol Scand 162: 285-293, 1998.
11. Canas PE. The role of taurine and its derivatives on cellular hypoxia: a physiological view. Acta Physiol Pharmacol Ther Latinoam 42: 133-137, 1992.
12. Chang L, Xu J, Yu F, Zhao J, Tang X, Tang C. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids 27: 37-48, 2004.
13. Choy K, Beck K, Png FY, Wu BJ, Leichtweiss SB, Thomas SR, Hou JY, Croft KD, Mori TA, Stocker R. Processes involved in the sitespecific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 25: 1684-1690, 2005.
14. Conte Camerino D, Tricarico D, Pierno S, Desaphy JF, Liantonio A, Pusch M, Burdi R, Camerino C, Fraysse B, De Luca A. Taurine and skeletal muscle disorders. Neurochem Res 29: 135-142, 2004.
15. Curran-Everett D. Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol 279: R1-R8, 2000.
16. Dawson R, Biasetti M, Messina S, Dominy J. The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids 22: 309-324, 2002.
17. De Luca A, Pierno S, Liantonio A, Conte Camerino D. Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness. Neuromuscul Disord 12, Suppl 1: S142-S146, 2002.
18. Dunnett M, Harris RC. High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in equine and camel muscle and individual muscle fibres. J Chromatogr B Biomed Sci Appl 688: 47-55, 1997.
19. Duty S, Allen DG. The effects of glibenclamide on tetanic force and intracellular calcium in normal and fatigued mouse skeletal muscle. Exp Physiol 80: 529-541, 1995.
20. El Idrissi A. Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 34: 321-328, 2008.
21. 2+ influx and loss of cell membrane integrity in rat extensor digitorum longus muscle. Exp Physiol 90: 703-714, 2005.
22. Galloway SDR, Talanian JL, Shoveller AK, Heigenhauser GJF, Spriet LL. Seven days of oral taurine supplementation does not increase muscle taurine content or alter substrate metabolism during prolonged exercise in humans. J Appl Physiol 105: 643-651, 2008.
23. 2+ in muscle cell damage. Ann NY Acad Sci 1066: 166-180, 2005.
24. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 83: 731-801.
25. ATP channels depress force by reducing action potential amplitude in mouse EDL and soleus muscle. Am J Physiol Cell Physiol 285: C1467-C1474, 2003.
26. Haber CA, Lam TKT, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus IG. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 285: E744-E753, 2003.
27. Hamilton EJ, Berg HM, Easton CJ, Bakker AJ. The effect of taurine depletion on the contractile properties and fatigue in fast-twitch skeletal muscle of the mouse. Amino Acids 31: 273-278, 2006.
28. Han X, Patters AB, Jones DP, Zelikovic I, Chesney RW. The taurine transporter: mechanisms of regulation. Acta Physiol (Oxf) 187: 61-76, 2006.
29. Hansen SH, Andersen ML, Birkedal H, Cornett C, Wibrand F. The important role of taurine in oxidative metabolism. Adv Exp Med Biol 583: 129-35, 2006.
30. Huxtable R, Bressler R. Effect of taurine on a muscle intracellular membrane. Biochim Biophys Acta 323: 573-583, 1973.
31. Huxtable JR. Physiological actions of taurine. Physiol Rev 72: 101-163, 1992.
32. Iwata H, Obara T, Kim BK, Baba A. Regulation of taurine transport in rat skeletal muscle. J Neurochem 47: 158-163, 1986.
33. Jackson MJ, Jones DA, Edwards RH. Experimental skeletal muscle damage: the nature of the calcium-activated degenerative processes. Eur J Clin Invest 14: 369-374, 1984.
34. Jones DA, Jackson MJ, Edwards RH. Release of intracellular enzymes from an isolated mammalian skeletal muscle preparation. Clin Sci (Lond) 65: 196-201, 1983.
35. Jones DA. High- and low-frequency fatigue revisited. Acta Physiol Scand 156: 265-270, 1996.
36. Kingston R, Kelly CJ, Murray P. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr Pharm Des 10: 2401-2410, 2004.
37. Kingston R, Kearns S, Kelly C, Murray P. Effects of systemic and regional taurine on skeletal muscle function following ischaemia-reperfusion injury. J Orthop Res 23: 310-314, 2005.
38. Matsell DG, Bennett T, Han X, Budreau AM, Chesney RW. Regulation of the taurine transporter gene in the S3 segment of the proximal tubule. Kidney Int 52: 748-754, 1997.
39. Matsuzaki Y, Miyazaki T, Miyakawa S, Bouscarel B, Ikegami T, Tanaka N. Decreased taurine concentration in skeletal muscles after exercise for various durations. Med Sci Sports Exerc 34: 793-797, 2002.
40. McCall KE, Duncan CJ. Independent pathways causing cellular damage in mouse soleus muscle under hypoxia. Comp Biochem Physiol A 94: 799-804, 1989.
41. McLaughlin R, Bowler D, Kelly CJ, Kay E, Bouchier-Hayes D. Taurine protects against early and late skeletal muscle dysfunction secondary to ischaemia reperfusion injury. Eur J Surg 166: 375-379, 2000.
42. Mehta TR, Dawson R. Taurine is a weak scavenger of peroxynitrite and does not attenuate sodium nitroprusside toxicity to cells in culture. Amino Acids 20: 419-433, 2001.
43. Mendez J, Keys A. Density and composition of mammalian skeletal muscle. Metab Clin Exp 9: 184-199, 1960.
44. 2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10: 10-23, 2005.
45. 2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2: 221-226, 2007.
46. 2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 268: 117-127, 1999.
47. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71: 1085-1094, 2000.
48. Murphy RM, Stephenson DG, Lamb GD. Effect of creatine on contractile force and sensitivity in mechanically skinned single fibers from rat skeletal muscle. Am J Physiol Cell Physiol 287: C1589-C1595, 2004.
49. Murphy RM, Snow RJ, Lamb GD. μ-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans. Am J Physiol Cell Physiol 290: C116-C122, 2006.
50. Murphy RM, Goodman CA, McKenna MJ, Bennie J, Leikis M, Lamb GD. Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J Appl Physiol 103: 926-931, 2007.
51. 2+ storage levels in sarcoplasmic reticulum of fast- and slow-twitch fibres of rat. J Physiol 587: 443-460, 2009.
52. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88: 581-609, 2008.
53. Nandhini TA, Anuradha CV. Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose. Clin Chim Acta 336: 129-135, 2003.
54. 2+ sequestration by taurine. Biochem Pharmacol 58: 1123-1131, 1999.
55. Paolini C, Quarta M, Nori A, Boncompagni S, Canato M, Volpe P, Allen PD, Reggiani C, Protasi F. Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1. J Physiol 583: 767-784, 2007.
56. Parvez S, Tabassum H, Banerjee BD, Raisuddin S. Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice. Basic Clin Pharmacol Toxicol 102: 382-387, 2008.
57. Pierno S, De Luca A, Camerino C, Huxtable RJ, Camerino DC. Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. J Pharmacol Exp Ther 286: 1183-1190, 1998.
58. 2+ transport and phospholipid methyltransferase activity. J Cardiovasc Pharmacol 24: 286-292, 1994.
59. Schaffer SW, Azuma J, Madura JD. Mechanisms underlying taurinemediated alterations in membrane function. Amino Acids 8: 231-246, 1995.
60. Schaffer SW, Azuma J, Mozaffari M. The role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87: 91-99, 2009.
61. Scholte HR, Yu Y, Ross JD, Oosterkamp II, Boonman AMC, Busch HFM. Rapid isolation of muscle and heart mitochondria, the lability of oxidative phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds. Mol Cell Biochem 174: 61-66, 1997.
62. 2+ entry in skeletal muscle. J Biol Chem 278: 3286-92, 2003.
63. Shiny KS, Kumar SH, Farvin KH, Anandan R, Devadasan K. Protective effect of taurine on myocardial antioxidant status in isoprenalineinduced myocardial infarction in rats. J Pharm Pharmacol 57: 1313-1317, 2005.
64. Tappaz ML. Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem Res 29: 83-96, 2004.
65. Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, Richard I. Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol 23: 9127-9135, 2003.
66. Timbrell JA, Seabra V, Waterfield CJ. The in vivo and in vitro protective properties of taurine. Gen Pharmacol 26: 453-462, 1995.
67. Tricarico D, Barbieri M, Conte Camerino D. Taurine blocks ATPsensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor. Br J Pharmacol 130: 827- 834, 2000.
68. 2+-activated potassium channels of rat skeletal muscle fibers. J Pharmacol Exp Ther 298: 1167-1171, 2001.
69. Wan FS, Li GH, Zhang J, Yu LH, Zhao XM. Protective effects of taurine on myocardial mitochondria and their enzyme activities in rate with severe burn. Zhonghua Shao Shang Za Zhi 24: 171-174, 2008.
70. Wang J, Yan LI, Zhang L, Zhao J, Pang Y, Tang C, Zhang J. Taurine inhibits ischemia/reperfusion-induced compartment syndrome in rabbits. Acta Pharmacol Sin 26: 821-827, 2005.
71. Warskulat U, Flogel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW, Molojavyi A, Heller-Stilb B, Schrader J, Haussinger D. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J 18: 577-579, 2004.
72. Westerblad H, Allen DG. Changes of myoplasmic calcium concentration during fatigue in single mouse muscle fibers. J Gen Physiol 98: 615-635, 1991.
73. Yatabe Y, Miyakawa S, Ohmori H, Mishima H, Adachi T. Effects of taurine administration on exercise. Adv Exp Med Biol 643: 245-252, 2009.
74. Yildirim Z, Kilic N, Ozer C, Babul A, Take G, Erdogan D. Effects of taurine in cellular responses to oxidative stress in young and middle-aged rat liver. Ann NY Acad Sci 1100: 553-561, 2007.
75. Zhang SJ, Bruton JD, Katz A, Westerblad H. Limited oxygen diffusion accelerates fatigue development in mouse skeletal muscle. J Physiol 572: 551-559, 2006.